These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23159330)

  • 21. Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
    Theilmann W; Gericke B; Schidlitzki A; Muneeb Anjum SM; Borsdorf S; Harries T; Roberds SL; Aguiar DJ; Brunner D; Leiser SC; Song D; Fabbro D; Hillmann P; Wymann MP; Löscher W
    Neuropharmacology; 2020 Dec; 180():108297. PubMed ID: 32890589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779.
    Messina MP; Rauktys A; Lee L; Dabora SL
    BMC Pharmacol; 2007 Nov; 7():14. PubMed ID: 17986349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches.
    Ehninger D
    Neuropharmacology; 2013 May; 68():97-105. PubMed ID: 22626986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.
    Abs E; Goorden SM; Schreiber J; Overwater IE; Hoogeveen-Westerveld M; Bruinsma CF; Aganović E; Borgesius NZ; Nellist M; Elgersma Y
    Ann Neurol; 2013 Oct; 74(4):569-79. PubMed ID: 23720219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.
    Kenerson HL; Aicher LD; True LD; Yeung RS
    Cancer Res; 2002 Oct; 62(20):5645-50. PubMed ID: 12384518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
    Ehninger D; Han S; Shilyansky C; Zhou Y; Li W; Kwiatkowski DJ; Ramesh V; Silva AJ
    Nat Med; 2008 Aug; 14(8):843-8. PubMed ID: 18568033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.
    Erbayat-Altay E; Zeng LH; Xu L; Gutmann DH; Wong M
    Epilepsia; 2007 Aug; 48(8):1470-6. PubMed ID: 17484760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.
    Reith RM; McKenna J; Wu H; Hashmi SS; Cho SH; Dash PK; Gambello MJ
    Neurobiol Dis; 2013 Mar; 51():93-103. PubMed ID: 23123587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
    Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
    Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral effects of alpha-alkylated amino acid analogs in the C57BL/6J mouse.
    Sase A; Brückner H; Höger H; Pollak A; Lubec G
    Behav Brain Res; 2013 Sep; 252():432-8. PubMed ID: 23756141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetic model to dissect the role of Tsc-mTORC1 in neuronal cultures.
    Nie D; Sahin M
    Methods Mol Biol; 2012; 821():393-405. PubMed ID: 22125080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
    García-Peñas JJ; Carreras-Sááez I
    Rev Neurol; 2013 Feb; 56 Suppl 1():S153-61. PubMed ID: 23446718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
    Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
    Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving neurobiology of tuberous sclerosis complex.
    Crino PB
    Acta Neuropathol; 2013 Mar; 125(3):317-32. PubMed ID: 23386324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.
    Fang F; Sun S; Wang L; Guan JL; Giovannini M; Zhu Y; Liu F
    J Bone Miner Res; 2015 Jul; 30(7):1195-205. PubMed ID: 25639352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired synaptic plasticity in a rat model of tuberous sclerosis.
    von der Brelie C; Waltereit R; Zhang L; Beck H; Kirschstein T
    Eur J Neurosci; 2006 Feb; 23(3):686-92. PubMed ID: 16487150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.
    Ehninger D; Silva AJ
    Behav Genet; 2011 May; 41(3):357-63. PubMed ID: 20882401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.